BTC Health Stock

BTC Health P/S

The (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of BTC Health (BTC.AX) as of Jul 23, 2026 is 2,466.00. In the previous year, (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. was 1,503.66 — a change of 64.00% (higher).

P/S

2,466.00

YoY

64.00%

Last updated:

As of Jul 23, 2026, BTC Health's P/S ratio stood at 2,466.00, a 64.00% change from the 1,503.66 P/S ratio recorded in the previous year.

The BTC Health P/S history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/S
Date
P/S
Jan 1, 2018
287.07 base
Jan 1, 2019
79.04 base
Jan 1, 2020
127.51 base
Jan 1, 2021
0.00 base
Jan 1, 2022
109.77 base
Jan 1, 2023
0.00 base
Jan 1, 2024
0.00 base
Jan 1, 2025
0.00 base
YEARP/S
2025 -
2024 -
2023 -
2022 109.77
2021 -
2020 127.51
2019 79.04
2018 287.07
2017 -
2016 159.52
2015 -
2014 342.93
2013 46.59
2012 52.18
2011 58.81
2010 8.03
2009 83.72
2008 19.34
2007 44.19
2006 58.72
Access this data via the Eulerpool API

BTC Health Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides BTC Health's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates BTC Health's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots BTC Health's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if BTC Health grows earnings faster than its peers.

BTC Health Stock analysis

What does BTC Health do? BTC Health Ltd is a British company specializing in the production and distribution of medical devices and pharmaceuticals. The company was founded in 2005 and is headquartered in London. Business model BTC Health Ltd's business model is based on the manufacturing and distribution of medical devices and pharmaceuticals that meet the highest quality standards. The company works closely with medical professionals and research institutions to develop innovative products that meet the needs of patients and healthcare providers. Divisions BTC Health Ltd is divided into several divisions, each offering different products and services. The main divisions are: - Medical Technology - Diagnostics - Pharmaceuticals Medical Technology The Medical Technology division manufactures a wide range of medical devices, including ventilators, infusion pumps, defibrillators, and patient monitors. These devices are used in hospitals, clinics, and care facilities to accurately monitor and treat patients. Diagnostics The Diagnostics division offers a variety of laboratory and diagnostic products, including blood glucose monitors, test strips, immunassays, and ELISA kits. These products are used for the rapid and reliable identification of diseases, enabling effective treatment. Pharmaceuticals The Pharmaceuticals division specializes in the production and distribution of innovative pharmaceuticals specifically developed for the treatment of rare diseases and serious illnesses. Products include cancer medications, antibody therapeutics, and treatments for rare metabolic disorders. Products BTC Health Ltd offers a wide range of medical devices and pharmaceuticals that meet the highest quality standards. Some of the key products include: - VasoPress (medication for the treatment of low blood pressure) - Episcan (ultrasound device for early detection of breast cancer) - Novotest (test for diagnosing kidney dysfunction) - Bongo (infusion pump for medication dosing) - Nonin Xpod (patient monitor for monitoring vital signs) Conclusion BTC Health Ltd is a leading company in the production and distribution of medical devices and pharmaceuticals. The company is committed to developing innovative products that meet the needs of patients and healthcare providers. With a wide range of products in various divisions, BTC Health Ltd is well positioned to be an important partner in the healthcare industry in the future. BTC Health is one of the most popular companies on Eulerpool.

P/S Details

Decoding BTC Health's P/S Ratio

BTC Health's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing BTC Health's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating BTC Health's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in BTC Health’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about BTC Health stock

(Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of BTC Health is 2,466.00 in 2026.

The P/S ratio when valuing a stock.

The price-to-sales ratio (P/S ratio) is an important tool of technical analysis that assists investors in evaluating stocks. It refers to the earnings per share of a company and its price movements. This indicator can be used to determine a stock's fair value, relative to the company's earnings.

History of the Price-to-Sales Ratio

The price-to-sales ratio is a relatively new indicator. It was first used in the 1980s by John Price when he developed the Price-to-Sales Index (PSI). Price wanted to find a way to value stocks taking into account their earnings. He noticed that many stock prices were not in line with their earnings situation. The PSI has since become an important analytical tool and is often referred to as the P/S ratio.

Calculation of the price-to-sales ratio

The price-to-sales ratio is easy to calculate. It is determined by dividing the current stock price by the company's earnings per share. P/S ratio = Stock price / Earnings per share. For example, if a company's stock price is $10 and the earnings per share is $2, then the P/S ratio is 5.

Application of the Price-to-Sales Ratio

The Price-to-Sales ratio is a useful tool for determining a fairly valued stock price. A low P/S ratio may indicate that a stock price is undervalued, which could be a good entry opportunity. However, a high Price-to-Sales ratio may indicate that a stock price is overvalued and investors should exercise caution.

An example: A company has a stock price of 20 USD and an earnings per share of 2 USD. The P/E ratio is 10. This could indicate that the stock price is overvalued and investors should be cautious before buying.

Investors and the price-to-sales ratio

Investors use the price-to-sales ratio to determine whether a company's stock price is fairly valued or not. They can compare the P/S ratio to see how the stock price relates to the company's earnings. Investors can also observe the P/S ratio over a longer period of time to see if the stock price changes in relation to the company's earnings.

Advantages and Disadvantages of the Price-to-Sales Ratio

The greatest advantage of the price-to-sales ratio is that it is a simple and understandable tool to determine the fair value of a stock price. It can also help investors identify stocks that are undervalued. One disadvantage is that the P/S ratio does not provide information about the company's profits. Therefore, investors should also consider other financial ratios before investing.

In today's time, the price-to-sales ratio is an important tool for investors to evaluate stocks and identify potential investment opportunities. It can help find a fairly valued stock price and identify stocks that are undervalued. However, investors should also consider other financial indicators before making an investment decision.

Access this data via the Eulerpool API

Valuation — BTC Health

All Key Metrics — BTC Health